These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32528972)

  • 21. Solution structure of SHIP2 SH2 domain and its interaction with a phosphotyrosine peptide from c-MET.
    Wang Z; Nie Y; Zhang K; Xu H; Ramelot TA; Kennedy MA; Liu M; Zhu J; Yang Y
    Arch Biochem Biophys; 2018 Oct; 656():31-37. PubMed ID: 30165040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
    Lubman OY; Waksman G
    J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The SH2 domain from the tyrosine kinase Fyn in complex with a phosphotyrosyl peptide reveals insights into domain stability and binding specificity.
    Mulhern TD; Shaw GL; Morton CJ; Day AJ; Campbell ID
    Structure; 1997 Oct; 5(10):1313-23. PubMed ID: 9351806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diversity in peptide recognition by the SH2 domain of SH2B1.
    McKercher MA; Guan X; Tan Z; Wuttke DS
    Proteins; 2018 Feb; 86(2):164-176. PubMed ID: 29127727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct determination of the sequence recognition requirements of the SH2 domains of SH-PTP2.
    Huyer G; Li ZM; Adam M; Huckle WR; Ramachandran C
    Biochemistry; 1995 Jan; 34(3):1040-9. PubMed ID: 7530043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal structure and NMR studies of the apo SH2 domains of ZAP-70: two bikes rather than a tandem.
    Folmer RH; Geschwindner S; Xue Y
    Biochemistry; 2002 Dec; 41(48):14176-84. PubMed ID: 12450381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
    Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
    J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A.
    Li SC; Gish G; Yang D; Coffey AJ; Forman-Kay JD; Ernberg I; Kay LE; Pawson T
    Curr Biol; 1999 Dec; 9(23):1355-62. PubMed ID: 10607564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A specific intermolecular association between the regulatory domains of a Tec family kinase.
    Brazin KN; Fulton DB; Andreotti AH
    J Mol Biol; 2000 Sep; 302(3):607-23. PubMed ID: 10986122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular recognition by SH2 domains.
    Bradshaw JM; Waksman G
    Adv Protein Chem; 2002; 61():161-210. PubMed ID: 12461824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternative modes of binding of proteins with tandem SH2 domains.
    O'Brien R; Rugman P; Renzoni D; Layton M; Handa R; Hilyard K; Waterfield MD; Driscoll PC; Ladbury JE
    Protein Sci; 2000 Mar; 9(3):570-9. PubMed ID: 10752619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structure of the C-terminal SH2 domain of the p85alpha regulatory subunit of phosphoinositide 3-kinase: an SH2 domain mimicking its own substrate.
    Hoedemaeker FJ; Siegal G; Roe SM; Driscoll PC; Abrahams JP
    J Mol Biol; 1999 Oct; 292(4):763-70. PubMed ID: 10525402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction and analysis of SH2 domain-phosphopeptide interactions.
    Zvelebil MJ; Panayotou G; Linacre J; Waterfield MD
    Protein Eng; 1995 Jun; 8(6):527-33. PubMed ID: 8532676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solution structure of the human pp60c-src SH2 domain complexed with a phosphorylated tyrosine pentapeptide.
    Xu RX; Word JM; Davis DG; Rink MJ; Willard DH; Gampe RT
    Biochemistry; 1995 Feb; 34(7):2107-21. PubMed ID: 7532003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterizing SH2 Domain Specificity and Network Interactions Using SPOT Peptide Arrays.
    Liu BA
    Methods Mol Biol; 2017; 1555():357-373. PubMed ID: 28092043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro phosphorylation of the epidermal growth factor receptor autophosphorylation domain by c-src: identification of phosphorylation sites and c-src SH2 domain binding sites.
    Lombardo CR; Consler TG; Kassel DB
    Biochemistry; 1995 Dec; 34(50):16456-66. PubMed ID: 8845374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of affinities for lck SH2 binding peptides using a sensitive fluorescence assay: comparison between the pYEEIP and pYQPQP consensus sequences reveals context-dependent binding specificity.
    Cousins-Wasti RC; Ingraham RH; Morelock MM; Grygon CA
    Biochemistry; 1996 Dec; 35(51):16746-52. PubMed ID: 8988011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A yeast two-hybrid study of human p97/Gab2 interactions with its SH2 domain-containing binding partners.
    Crouin C; Arnaud M; Gesbert F; Camonis J; Bertoglio J
    FEBS Lett; 2001 Apr; 495(3):148-53. PubMed ID: 11334882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of early and late transition states of the folding pathway of a SH2 domain.
    Toto A; Malagrinò F; Nardella C; Pennacchietti V; Pagano L; Santorelli D; Diop A; Gianni S
    Protein Sci; 2022 Jun; 31(6):e4332. PubMed ID: 35634781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.